Pregnant C57BI6/J mice treated with a CSE inhibitor, dl-Propargylglycine (PAG), develop ‘preeclampsia phenotype’, characterised by hypertension, kidney damage and fetal growth restriction (FGR) [25]. This evidence concerns the gene CTH and preeclampsia.